Timothy G. Youngquist 2020 Irrevocable Trust’s Context Therapeutics CNTX Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio CNTX Stock Details CNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Buy	+198,384	New	+$402K	0.02%	75

Other funds holding CNTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's CNTX Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust opened a new position in Context Therapeutics (CNTX) in Q2 2026: 198,384 shares worth $110K. The stake represents 0.02% of the portfolio and ranks #75 among its holdings.

17 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

Timothy G. Youngquist 2020 Irrevocable Trust held 198,384 shares of Context Therapeutics worth $110K as of Q2 2026.
Context Therapeutics was a new Timothy G. Youngquist 2020 Irrevocable Trust position in Q2 2026.
Context Therapeutics made up 0.02% of Timothy G. Youngquist 2020 Irrevocable Trust's portfolio in Q2 2026, its #75 holding.
17 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.